PayPay Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

PayPay Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25K	Hold	2	–	–	0.03%	208
2026 Q1	$1.49K	Sell	2 -1	-33%	-$766	0.05%	200
2025 Q4	$2.32K	Buy	3 +1	+50%	+$679	0.07%	174
2025 Q3	$934	Sell	2 -1	-33%	-$565	0.03%	256
2025 Q2	$1.57K	Buy	3 +1	+50%	+$558	0.08%	171
2025 Q1	$1.32K	Sell	2 -3	-60%	-$2.06K	0.08%	204
2024 Q4	$3.56K	Buy	+5	New	+$4.2K	0.15%	112

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PayPay Securities's REGN Position: Q2 2026 in Review

PayPay Securities held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2 shares worth $1.25K. The position accounts for 0.03% of the portfolio, ranked #208.

PayPay Securities first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.56K in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

PayPay Securities held 2 shares of Regeneron Pharmaceuticals worth $1.25K as of Q2 2026.
PayPay Securities left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.03% of PayPay Securities's portfolio in Q2 2026, its #208 holding.
PayPay Securities first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
PayPay Securities's Regeneron Pharmaceuticals position peaked at $3.56K in Q4 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.